Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunologyOncology Open Access | 10.1172/jci.insight.205779

CDH3-directed immunotherapy targets basal-like hormone receptor negative prostate cancer and breast cancer

Guoqiang Liu,1 Shiyu Wang,2 Ziyu Zeng,2 Loan Duong,1 Jing Yang,2 Nipuni Barupala,2 Yun Zhao,2 Sharif Rahmy,1 Shan Feng,2 Xiaotian Chi,2 Ariana Arce,2 Linchuan Jia,3 Jun Wan,4 Liang Cheng,5 Xuemin Lu,2 and Xin Lu1

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Liu, G. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Wang, S. in: PubMed | Google Scholar |

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Zeng, Z. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Duong, L. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Yang, J. in: PubMed | Google Scholar |

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Barupala, N. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Zhao, Y. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Rahmy, S. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Feng, S. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Chi, X. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Arce, A. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Jia, L. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Wan, J. in: PubMed | Google Scholar |

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Cheng, L. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Lu, X. in: PubMed | Google Scholar

1Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, United States of America

2Department of Biological Sciences, University of Notre Dame, Notre Dame, United States of America

3iSURE Program, University of Notre Dame, Notre Dame, United States of America

4Department of Medical and Molecular Genetics, Center for Computational Biol, Indiana University School of Medicine, Indianapolis, United States of America

5Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, United States of America

Find articles by Lu, X. in: PubMed | Google Scholar

Published November 3, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.205779.
Copyright © 2026, Liu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 3, 2026 - Version history
View PDF
Abstract

Basal-like double-negative prostate cancer (DNPC) and triple-negative breast cancer (TNBC) are aggressive tumors with few targeted treatment options, raising the question of whether a shared, druggable cell-surface antigen can be leveraged for effective immunotherapy. Here, we integrated analyses of independent bulk and single-cell transcriptomic datasets with mechanistic and preclinical therapeutic studies to evaluate CDH3 (P-cadherin) as a candidate target in basal-like disease. CDH3 expression was consistently enriched in basal-like subtypes across prostate and breast cancer cohorts and was preferentially expressed in basal epithelial tumor compartments. Mechanistically, CDH3 expression was governed by a YAP1–WNT5A/ROR2 signaling axis, linking basal subtype gene expression to non-canonical Wnt signaling. To exploit this target, we evaluated both a CDH3-directed antibody-drug conjugate (ADC) and CDH3-specific chimeric antigen receptor (CAR)-T cells. The ADC exhibited antigen-dependent internalization and cytotoxicity in vitro and reduced metastatic tumor burden in vivo. CDH3 CAR-T cells showed antigen-specific activation and tumor cell killing in vitro and improved tumor control and survival in metastatic prostate and breast cancer xenograft models, with additional benefit when combined with PD-1 blockade (nivolumab). Together, these findings establish CDH3 as a clinically relevant and therapeutically actionable target and support CDH3-directed ADC and CAR-T strategies for aggressive, basal-like DNPC and TNBC.

Supplemental material

View Unedited blot and gel images

View

Version history
  • Version 1 (November 3, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts